Commercial Wegovy pill launches in UK as first daily oral GLP1 for weight management pharminent July 6, 2026
News BioNTech Held Buyer Talks Over Four German Sites Set to Close, Handelsblatt Reports pharminent July 3, 2026
News Roche’s Divarasib Beats Amgen and BMS Head-to-Head in Phase 3 KRAS Lung Cancer Trial pharminent July 2, 2026
Regulatory Novartis receives European Commission approval for Itvisma for spinal muscular atrophy pharminent July 2, 2026
Manufacturing FDA Selects Seven for PreCheck Pilot to Advance Drug Manufacturing pharminent July 1, 2026
News Ipsen Acquires Memo Therapeutics for Up to €700M in Second Deal in Three Days pharminent July 1, 2026
M&A / Deals Ipsen to buy Swiss biotech Memo Therapeutics in potential $800M deal pharminent July 1, 2026
Pipeline AlzeCure enters collaboration agreement with QuantumCell ApS for NeuroRestore project pharminent July 1, 2026
Regulatory Eli Lilly and Regeneron among 7 companies picked for FDA PreCheck pilot program pharminent July 1, 2026
Clinical Data EAN 2026: Real-world data supports safety and efficacy of AbbVie’s Vyalev in Parkinson’s pharminent July 1, 2026
Regulatory Sarepta secures early 2027 FDA decision for Duchenne drugs, pushing past confirmatory fail pharminent July 1, 2026
News NEJM Retracts Pivotal Tavneos Paper as Amgen’s FDA Data-Integrity Fight Deepens pharminent June 30, 2026
Clinical Data Evommune ends development of lead asset in chronic hives after mid-stage efficacy woes pharminent June 30, 2026
News Viridian’s Lumvoa Wins FDA Approval, Taking Direct Aim at Amgen’s Tepezza in Thyroid Eye Disease pharminent June 29, 2026
Clinical Data BridgeBio’s achondroplasia pill shows ‘compelling’ growth and body proportionality benefit pharminent June 29, 2026
Regulatory Lilly’s Jaypirca receives CHMP positive opinion for CLL in Europe pharminent June 29, 2026
Regulatory Replimune gets early August decision date for twice-rejected melanoma drug pharminent June 26, 2026
